文献速递流行病学与生物统计真实世界研究与卫生经济临床试验与 GCP

两项研究者发起的随机试验资源使用与成本的回顾性评估及综合成本项目清单

Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list.
PubMed 文献 · J Clin Epidemiol · 2017-12-30

该研究采用半结构化访谈和系统制定的成本项目清单,回顾性评估了两项研究者发起的随机对照试验的资源使用与详细成本。Oxantel试验(ISRCTN54577342)花费798个工作日、总成本10万美元且与原计划一致。两项试验的成本驱动因素相似,Prednisone试验的额外成本由招募延迟解释。

要点

  • Oxantel试验总成本10万美元,与原计划一致,花费798个工作日。
  • 两项试验成本驱动因素相似,该案例提供了透明评估试验资源与成本的方法。

核心结论

  • 该案例研究提供了透明评估随机对照试验资源与成本的示例,并呈现了费用类型与规模的详细经验数据。
  • 未来该模型方法可帮助他人规划、评估或监测随机对照试验的资源使用与成本。

研究设计与样本

  • 对两项研究者发起的随机对照试验(Prednisone试验NCT00973154和Oxantel试验ISRCTN54577342)进行回顾性评估。
  • 通过半结构化访谈和系统制定的成本项目清单以标准化方式经验性评估资源使用,并结合年度薪资信息将资源使用转化为成本。
  • 收集所有「其他成本」包括固定价格项目,计算总体成本及各研究阶段成本。

主要发现

  • Oxantel试验花费798个工作日,总成本为原计划的10万美元。
  • 两项随机对照试验的成本驱动因素相似,招募延迟解释了Prednisone试验的额外成本。

关键数值与推荐

  • Oxantel试验(ISRCTN54577342)花费798个工作日,总成本10万美元,与原计划一致。

临床怎么用

  • 该模型方法可用于规划、评估或监测随机对照试验的资源使用与成本。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Randomized clinical trials (RCTs) are costly and published information on resource requirements for their conduct is limited. To identify key factors for making RCTs more sustainable, empirical data on resource use and associated costs are needed. We aimed to retrospectively assess resource use and detailed costs of two academic, investigator-initiated RCTs using a comprehensive list of cost items. STUDY DESIGN AND SETTING: The resource use of two investigator-initiated RCTs (Prednisone-Trial [NCT00973154] and Oxantel-Trial [ISRCTN54577342]) was empirically assessed in a standardized manner through semistructured interviews and a systematically developed cost item list. Using information about yearly salaries, resource use was translated into costs. In addition, we collected all "other costs" including fixed priced items. Overall costs as well as cost of different study phases were calculated. RESULTS: The personnel time used in the Prednisone-Trial trial was approximately 2,897 working days and the overall costs were calculated to be USD 2.3 million, which was USD 700,000 more than planned. In the Oxantel-Trial 798 working days were spent and the overall costs were as originally planned USD 100,000. Cost drivers were similar between the two RCTs with recruitment delays explaining the additional costs in the Prednisone-Trial. CONCLUSION: This case study provides an example of how to transparently assess resources and costs of RCTs and presents detailed empirical data on type and magnitude of expenses. In the future, this model approach may serve others to plan, assess, or monitor resource use and costs of RCTs.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Speich B, von Niederhäusern B, Blum CA, et al. Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list. J Clin Epidemiol. 2017. PMID: 29292203. doi:10.1016/j.jclinepi.2017.12.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。